Post Covid-19 Evaluation Of Patients With Cardiac Complaints By Using Echocardiography

INTRODUCTION: Cardiac sequelae aren’t clearly known in people who recovered from COVID-19 disease.
METHODS: : In this study, we evaluated symptomatic patients by using echocardiography
RESULTS: In this study were included patients who recovered from COVID-19 disease and presented to the cardiology outpatient clinics. These patients were divided into two groups: those presenting within the first 30 days after recovery and those presenting between 30 and 60 days after recovery. Thirty patients who had not had COVID-19 before, who applied to the cardiology outpatient clinics, were selected as the control group
DISCUSSION AND CONCLUSION: The rate of dizziness, palpitations, chest pain and blood pressure dysregulation did not differ significantly between group I(patients presenting within 30 days after recovery), group II(patients presenting between 30 and 60 days after recovery), and group III(control group) (p> 0.05). Dyspnea rate in group I was significantly higher than group II and group III. There was a difference between groups in left ventricular ejection fraction. In group III, sPAP ≥ 35 mmHg ratio was significantly lower than group I and group II (p <0.05). sPAP ≥ 35 mmHg ratio did not differ significantly (p> 0.05) between group I and group II. While dyspnea was an important complaint in the first periods, it decreased over time. In addition, it was observed that right ventricular functions and left ventricular diastolic functions improved over time. It is noteworthy that there are more patients with pericardial effusion compared to the control group, which shows us that the inflammation process is continuing